» Articles » PMID: 36405057

Analysis on Internal Mechanism of Zedoary Turmeric in Treatment of Liver Cancer Based on Pharmacodynamic Substances and Pharmacodynamic Groups

Overview
Journal Chin Herb Med
Publisher Elsevier
Date 2022 Nov 21
PMID 36405057
Authors
Affiliations
Soon will be listed here.
Abstract

Zedoary tumeric (, Ezhu in Chinese) has a long history of application and has great potential in the treatment of liver cancer. The antiliver cancer effect of zedoary tumeric depends on the combined action of multiple pharmacodynamic substances. In order to clarify the specific mechanism of zedoary tumeric against liver cancer, this paper first analyzes the mechanism of its single pharmacodynamic substance against liver cancer, and then verifies the joint anti liver cancer mechanism of its "pharmacodynamic group". By searching the research on the antihepatoma effect of active components of zedoary tumeric in recent years, we found that pharmacodynamic substances, including curcumol, zedoarondiol, curcumenol, curzerenone, curdione, curcumin, germacrone, β-elemene, can act on multi-target and multi-channel to play an antihepatoma role. For example, curcumin can regulate miR, GLO1, CD133, VEGF, YAP, LIN28B, GPR81, HCAR-1, P53 and PI3K/Akt/mTOR, HSP70/TLR4 and NF-κB. Wnt/TGF/EMT, Nrf2/Keap1, JAK/STAT and other pathways play an antihepatoma role. Network pharmacological analysis showed that the core targets of the "pharmacodynamic group" for anti-life cancer are AKT1, EGFR, MAPK8, etc, and the core pathways are neuroactive live receiver interaction, nitrogen metabolism, HIF-1 signaling pathway, etc. At the same time, by comparing and analyzing the relationship between the specific mechanisms of pharmacodynamic substance and "pharmacodynamic group", it is found that they have great reference significance in target, pathway, biological function, determination of core pharmacodynamic components, formation of core target protein interaction, in-depth research of single pharmacodynamic substance, increasing curative effect and so on. By analyzing the internal mechanism of zedoary tumeric pharmacodynamic substance and "pharmacodynamic group" in the treatment of liver cancer, this paper intends to provide some ideas and references for the deeper pharmacological research of zedoary tumeric and the relationship between pharmacodynamic substance and "pharmacodynamic group".

Citing Articles

Mechanisms of T-cell Depletion in Tumors and Advances in Clinical Research.

Su X, Zhang M, Zhu H, Cai J, Wang Z, Xu Y Biol Proced Online. 2025; 27(1):5.

PMID: 39905296 PMC: 11792740. DOI: 10.1186/s12575-025-00265-6.


Curzerenone inactivates the nuclear factor-kappa B signaling to suppress malignancy and immune evasion in cervical cancer by targeting CSNK2B.

Sun Y, Wang M, Ling J, Wu Q, Han G, Zhou J Hum Cell. 2024; 38(1):35.

PMID: 39718697 DOI: 10.1007/s13577-024-01164-w.


Network pharmacology prediction and experiment validation of anti-liver cancer activity of Curcumae Rhizoma and Hedyotis diffusa Willd.

Tie S, Tong T, Zhan G, Li X, Ouyang D, Cao J Ann Med Surg (Lond). 2024; 86(6):3337-3348.

PMID: 38846818 PMC: 11152801. DOI: 10.1097/MS9.0000000000002074.


Analysis of GC × GC fingerprints from medicinal materials using a novel contour detection algorithm: A case of .

Yang X, Sima Y, Luo X, Li Y, He M J Pharm Anal. 2024; 14(4):100936.

PMID: 38655399 PMC: 11036100. DOI: 10.1016/j.jpha.2024.01.004.


Effect of et and on liver protection mechanism based on pharmacokinetics and metabonomics.

Feng G, Bi J, Jin W, Wang Q, Dan Z, Fan B Chin Herb Med. 2024; 16(1):121-131.

PMID: 38375045 PMC: 10874764. DOI: 10.1016/j.chmed.2023.10.002.

References
1.
Hinz N, Jucker M . Distinct functions of AKT isoforms in breast cancer: a comprehensive review. Cell Commun Signal. 2019; 17(1):154. PMC: 6873690. DOI: 10.1186/s12964-019-0450-3. View

2.
Di J, Gao K, Qu D, Yang J, Zheng J . Rap2B promotes angiogenesis via PI3K/AKT/VEGF signaling pathway in human renal cell carcinoma. Tumour Biol. 2017; 39(7):1010428317701653. DOI: 10.1177/1010428317701653. View

3.
Shao S, Duan W, Xu Q, Li X, Han L, Li W . Curcumin Suppresses Hepatic Stellate Cell-Induced Hepatocarcinoma Angiogenesis and Invasion through Downregulating CTGF. Oxid Med Cell Longev. 2019; 2019:8148510. PMC: 6360067. DOI: 10.1155/2019/8148510. View

4.
Li Z, Peng Y, Li J, Chen Z, Chen F, Tu J . N-methyladenosine regulates glycolysis of cancer cells through PDK4. Nat Commun. 2020; 11(1):2578. PMC: 7244544. DOI: 10.1038/s41467-020-16306-5. View

5.
Zhao Z, Malhotra A, Seng W . Curcumin Modulates Hepatocellular Carcinoma by Reducing UNC119 Expression. J Environ Pathol Toxicol Oncol. 2019; 38(3):195-203. DOI: 10.1615/JEnvironPatholToxicolOncol.2019029549. View